Keyword: Xarelto

News

Bayer and J&J Settle 25,000 Xarelto Claims

28.03.2019 - At a cost of $775 million, Bayer and Johnson & Johnson have agreed to settle claims by patients against the top-selling anticoagulant Xarelto out of court. The two drugmakers said...

News

FDA Confirms Xarelto Safety Profile

19.01.2018 - A report from the US Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety has confirmed the safety profile and effectiveness of the anticoagulant...

News

First Loss for Bayer and J&J in Xarelto Suits

12.12.2017 - In the fourth of three lawsuits heard by US courts over the risks of the blockbuster blood thinner Xarelto to date, a jury in Philadelphia, Pennsylvania, last week ordered Bayer...

News

Bayer and J&J Win Third Xarelto Case

22.08.2017 - Germany’s Bayer and Johnson & Johnson (J&J) of the US have won the third of three lawsuits involving bleeding risks of the blockbuster blood thinner Xarelto, which was developed...

News

J&J and Bayer Win First Xarelto Lawsuit

05.05.2017 - Bayer and Johnson & Johnson have won the first of around 18,000 lawsuits lawsuit being brought by US patients who claim the blood-thinning drug Xarelto caused their uncontrollable...

News

Bayer Has “Great Plans” for Life Sciences, CEO Says

12.03.2015 - Bayer aims to achieve strong sales and earnings growth for its life science businesses in the coming years, CEO Marijn Dekkers said at the "Meet Management" investor conference in...

News

Bayer Buoyed by Health and Agriculture in Q3

31.10.2014 - Buoyed by a strong performance in its Healthcare and CropScience businesses in the third quarter, Bayer has raised its forecast for full year 2014. CEO Marijn Dekkers said he...

News

Bayer Said to Face US Litigation Over Xarelto Side Effects

16.10.2014 - Bayer soon may find itself regretting its decision to sell its plastics business and become a pure life science player. According to international press reports, the German group's...